In vivo intrinsic efficacy of the 5-HT1A receptor antagonists NAD-299, WAY-100,635 and (S)-(-)-UH-301 at rat brain monoamine receptors1Presented in part at the `9th ECNP Congress', Amsterdam, September 21–25, 1996 (Ahlenius et al., 1996).1